![]()
|
Report Date : |
23.01.2008 |
IDENTIFICATION
DETAILS
|
Name : |
EKIN MEDIKAL DIS TICARET A.S. |
|
|
|
|
Registered Office : |
Inonu Mah Cimen Sok No:74/1 Harbiye- Istanbul/ |
|
|
|
|
Country : |
Turkey |
|
|
|
|
Financials (as on) : |
31.12.2006 |
|
|
|
|
Date of Incorporation : |
25.03.2004 (Commercial Registry Gazette Date/No: 30.03.2004/6018 ) |
|
|
|
|
Com. Reg. No.: |
519179 |
|
|
|
|
Legal Form : |
Private Limited |
|
|
|
|
Line of Business : |
Trade of medical materials |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Slow but Correct |
|
|
|
|
Litigation : |
Clear |
|
NAME |
: |
EKIN MEDIKAL DIS TICARET A.S. |
|
ADDRESS |
: |
Head Office: Inonu Mah Cimen Sok No:74/1 Harbiye- Istanbul/ Turkey |
|
PHONE NUMBER |
: |
90-212-291 55 95 (pbx) |
|
FAX NUMBER |
: |
90-212-291 42 74 |
|
TAX OFFICE / NO |
: |
Beyoglu / 3280309752 |
|
|
|
REGISTRATION NUMBER |
: |
519179 |
|
|
|
REGISTERED OFFICE |
: |
Istanbul Chamber of Commerce |
|
|
|
DATE ESTABLISHED |
: |
25.03.2004 (Commercial Registry Gazette Date/No: 30.03.2004/6018 ) |
|
|
|
LEGAL FORM |
: |
Joint Stock Company |
|
|
|
TYPE OF COMPANY |
: |
Private |
|
|
|
REGISTERED CAPITAL |
: |
YTL 500,000 |
|
|
|
PAID-IN CAPITAL |
: |
YTL 500,000 |
|
|
|
HISTORY |
: |
|
|
|
|
|
|
Previous Registered Capital |
: YTL 50,000 |
|
|
|
|
Regist. Capital Changed on |
: 07.11.2005 (Commercial Registry Gazette Date/No: 10.11.2005/6428) |
|
|
SHAREHOLDERS |
: |
Aziz Kaya Duygu Kaya Ekin Kaya Ismet Sen Sema Demirtas |
65 % 10 % 10 % 10 % 5 % |
|
SISTER COMPANIES |
: |
Kultur Saglik Hizmetleri ve Dis Ticaret Ltd Sti. |
|
|
GROUP PARENT COMPANY |
: |
None |
|
|
SUBSIDIARIES |
: |
None |
|
|
BOARD OF DIRECTORS |
: |
Aziz Kaya Ekin Kaya Ismet Sen |
Chairman Member Member |
|
DIRECTORS |
: |
Aziz Kaya |
|
|
BUSINESS ACTIVITIES |
: |
Trade of medical materials The firm declared that, it is the distributor of the following
companies: -Diasys Europe (UK) -Isogen (Netherlands) -Ivagen (France) -Ultimed (Germany) -Oxford Immunotec (UK) -Invernes Medical (USA) -Anilab Systems (Finland) |
|
|
SECTOR |
: |
Commerce |
|
|
NUMBER OF EMPLOYEES |
: |
4 |
|
|
NET SALES |
: |
(YTL) 635,081 1,239,917 |
(2005) (2006) |
|
CAPACITY |
: |
None |
|
|
PRODUCTION |
: |
None |
|
|
IMPORT VALUE |
: |
(EUR) 200,000 |
(2006) |
|
IMPORT COUNTRIES |
: |
UK, France… |
|
|
MERCHANDISE IMPORTED |
: |
Medical materials |
|
|
PREMISES |
: |
Head Office: Inonu Mah Cimen Sok No:74/1 Harbiye-Istanbul (400 sqm)
(owned) |
|
|
FIXED CAPITAL INVESTMENTS |
: |
None |
|
|
TREND OF BUSINESS |
: |
Upwards in 2006 |
|
SIZE OF BUSINESS |
: |
Lower- moderate |
|
MAIN DEALING BANKERS |
: |
T.Halk Bankasi Kucukkoy branch in Istanbul Kuveyt Turk Katilim Bankasi Taksim branch in Istanbul Yapi ve Kredi Bankasi Harbiye branch in Istanbul Turk Ekonomi Bankasi Cihangir branch in Istanbul |
|
CREDIT FACILITIES |
: |
The subject company is making use of credit facilities. |
|
PAYMENT BEHAVIOUR |
: |
We are informed about a few payment delays in the last years but most
of them were resolved later on. |
|
FINANCIAL STRUCTURE (SUFFICENCY OF OWN RESOURCES) |
|
|
|
In order |
As of 31.12.2006 |
|
|
LIQUIDITY |
|
|
|
In order |
As of 31.12.2006 |
|
|
PROFITABILITY |
|
|
|
High |
In 2006 |
|
|
GAP BETWEEN COLLECTION-PAYMENT PERIODS |
|
|
|
Favorable |
In 2006 |
|
|
GENERAL FINANCIAL POSITION |
|
|
|
In order |
|
|
|
CREDIT OPINION WITHOUT OBLIGATION |
: |
We are of the opinion that, a max. credit of USD 175,000 may be
granted to the subject company. |
|
|
Incr. in producers’ price index |
Average YTL/$ |
Average YTL/EUR |
Average YTL/GBP |
|
(2005) |
2.66 % |
1.3499 |
1.6882 |
2.4623 |
|
(2006) |
11.58 % |
1.4309 |
1.7987 |
2.6377 |
|
(1.1.-30.09.2007) |
4.98 % |
1.3447 |
1.8084 |
2.6720 |
|
(2007) |
5.94 % |
1.3075 |
1.7901 |
2.6133 |
BALANCE SHEETS
|
|
|
YTL |
|
|
|
YTL |
|
|
|
|
|
|
31.12.05 |
|
|
|
31.12.06 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CURRENT ASSETS |
822.070 |
|
0,93 |
|
1.093.654 |
|
0,74 |
|
|
|
Cash and
Banks |
637.094 |
|
0,72 |
|
355.918 |
|
0,24 |
|
|
|
Marketable Securities |
0 |
|
0,00 |
|
0 |
|
0,00 |
|
|
|
Account
Receivable |
43.789 |
|
0,05 |
|
144.981 |
|
0,10 |
|
|
|
Other
Receivable |
0 |
|
0,00 |
|
1.984 |
|
0,00 |
|
|
|
Inventories |
83.519 |
|
0,09 |
|
488.483 |
|
0,33 |
|
|
|
Advances
Given |
51.760 |
|
0,06 |
|
96.212 |
|
0,07 |
|
|
|
Other
Current Assets |
5.908 |
|
0,01 |
|
6.076 |
|
0,00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NON-CURRENT ASSETS |
60.823 |
|
0,07 |
|
377.263 |
|
0,26 |
|
|
|
Long-term
Receivable |
0 |
|
0,00 |
|
0 |
|
0,00 |
|
|
|
Financial
Assets |
0 |
|
0,00 |
|
0 |
|
0,00 |
|
|
|
Tangible
Fixed Assets (net) |
58.568 |
|
0,07 |
|
375.023 |
|
0,25 |
|
|
|
Intangible Assets |
0 |
|
0,00 |
|
2.240 |
|
0,00 |
|
|
|
Other
Non-Current Assets |
2.255 |
|
0,00 |
|
0 |
|
0,00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL ASSETS |
882.893 |
|
1,00 |
|
1.470.917 |
|
1,00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CURRENT LIABILITIES |
348.091 |
|
0,39 |
|
669.137 |
|
0,45 |
|
|
|
Financial
Loans |
81.458 |
|
0,09 |
|
382.729 |
|
0,26 |
|
|
|
Accounts
Payable |
204.471 |
|
0,23 |
|
249.109 |
|
0,17 |
|
|
|
Loans
from Shareholders |
0 |
|
0,00 |
|
0 |
|
0,00 |
|
|
|
Other
Short-term Payable |
44.984 |
|
0,05 |
|
9.212 |
|
0,01 |
|
|
|
Advances
from Customers |
0 |
|
0,00 |
|
364 |
|
0,00 |
|
|
|
Taxes
Payable |
7.994 |
|
0,01 |
|
27.723 |
|
0,02 |
|
|
|
Provisions |
9.184 |
|
0,01 |
|
0 |
|
0,00 |
|
|
|
Other
Current Liabilities |
0 |
|
0,00 |
|
0 |
|
0,00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LONG-TERM LIABILITIES |
0 |
|
0,00 |
|
100.043 |
|
0,07 |
|
|
|
Financial
Loans |
0 |
|
0,00 |
|
100.043 |
|
0,07 |
|
|
|
Securities Issued |
0 |
|
0,00 |
|
0 |
|
0,00 |
|
|
|
Long-term
Payable |
0 |
|
0,00 |
|
0 |
|
0,00 |
|
|
|
Loans
from Shareholders |
0 |
|
0,00 |
|
0 |
|
0,00 |
|
|
|
Other
Long-term Liabilities |
0 |
|
0,00 |
|
0 |
|
0,00 |
|
|
|
Provisions |
0 |
|
0,00 |
|
0 |
|
0,00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
STOCKHOLDERS' EQUITY |
534.802 |
|
0,61 |
|
701.737 |
|
0,48 |
|
|
|
Paid-in
Capital |
500.000 |
|
0,57 |
|
500.000 |
|
0,34 |
|
|
|
Reserves |
9.667 |
|
0,01 |
|
32.732 |
|
0,02 |
|
|
|
Revaluation Fund |
2.070 |
|
0,00 |
|
2.070 |
|
0,00 |
|
|
|
Accumulated
Losses(-) |
0 |
|
0,00 |
|
0 |
|
0,00 |
|
|
|
Net
Profit (loss) |
23.065 |
|
0,03 |
|
166.935 |
|
0,11 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL LIABILITIES AND EQUITY |
882.893 |
|
1,00 |
|
1.470.917 |
|
1,00 |
|
|
|
|
YTL |
|
|
|
YTL |
|
|
|
|
|
|
2005 |
|
|
|
2006 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Sales |
635.081 |
|
1,00 |
|
1.239.917 |
|
1,00 |
|
|
|
Cost of
Goods Sold |
392.889 |
|
0,62 |
|
721.691 |
|
0,58 |
|
|
|
Gross Profit |
242.192 |
|
0,38 |
|
518.226 |
|
0,42 |
|
|
|
Operating
Expenses |
197.658 |
|
0,31 |
|
273.125 |
|
0,22 |
|
|
|
Operating Profit |
44.534 |
|
0,07 |
|
245.101 |
|
0,20 |
|
|
|
Other
Income |
1.556 |
|
0,00 |
|
12.876 |
|
0,01 |
|
|
|
Other
Expenses |
478 |
|
0,00 |
|
6.972 |
|
0,01 |
|
|
|
Financial
Expenses |
12.662 |
|
0,02 |
|
84.070 |
|
0,07 |
|
|
|
Profit (loss) Before Tax |
32.950 |
|
0,05 |
|
166.935 |
|
0,13 |
|
|
|
Tax
Payable |
9.885 |
|
0,02 |
|
0 |
|
0,00 |
|
|
|
Net Profit (loss) |
23.065 |
|
0,04 |
|
166.935 |
|
0,13 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005 |
|
|
|
2006 |
|
|
|
|
|
LIQUIDITY RATIOS |
|
|
|
|
|
|
|
|
|
|
Current Ratio |
2,36 |
|
|
|
1,63 |
|
|
|
|
|
Acid-Test Ratio |
1,96 |
|
|
|
0,75 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ASSET STRUCTURE RATIOS |
|
|
|
|
|
|
|
|
|
|
Inventory/Total Assets |
0,09 |
|
|
|
0,33 |
|
|
|
|
|
Short-term Receivable/Total Assets |
0,05 |
|
|
|
0,10 |
|
|
|
|
|
Tangible Assets/Total Assets |
0,07 |
|
|
|
0,25 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TURNOVER RATIOS |
|
|
|
|
|
|
|
|
|
|
Inventory Turnover |
4,70 |
|
|
|
1,48 |
|
|
|
|
|
Stockholders' Equity Turnover |
1,19 |
|
|
|
1,77 |
|
|
|
|
|
Asset Turnover |
0,72 |
|
|
|
0,84 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FINANCIAL STRUCTURE |
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity/Total Assets |
0,61 |
|
|
|
0,48 |
|
|
|
|
|
Current Liabilities/Total Assets |
0,39 |
|
|
|
0,45 |
|
|
|
|
|
Financial Leverage |
0,39 |
|
|
|
0,52 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PROFITABILITY RATIOS |
|
|
|
|
|
|
|
|
|
|
Net Profit/Stockholders' Eq. |
0,04 |
|
|
|
0,24 |
|
|
|
|
|
Operating Profit Margin |
0,07 |
|
|
|
0,20 |
|
|
|
|
|
Net Profit Margin |
0,04 |
|
|
|
0,13 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
COLLECTION-PAYMENT |
|
|
|
|
|
|
|
|
|
|
Average Collection Period (days) |
24,82 |
|
|
|
42,09 |
|
|
|
|
|
Average Payable Period (days) |
187,35 |
|
|
|
124,26 |
|
|
|
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)